{
  "docId": "019dd923-5ca1-7489-b634-d3738a63434c",
  "docSlug": "2862941a98bffda6",
  "documentTitle": "Corporate Ventures in Sweden",
  "authorId": "BCG",
  "authorName": "BCG",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.445,
  "pageNumber": 26,
  "pageCount": 28,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "appendix_disclosure",
  "function": "cite_precedent",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": [
    "quote_block",
    "logo_grid"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b634-d3738a63434c/26",
  "deckHref": "/decks/019dd923-5ca1-7489-b634-d3738a63434c",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b634-d3738a63434c.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b634-d3738a63434c#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.45,
        "x": 0.54,
        "y": 0.31
      },
      "kind": "quote",
      "text": "The hub exposes AstraZeneca to more innovation and science. It stimulates an even more vibrant place to work and generates future collaboration opportunities.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "02545823-717c-431d-add1-99c4eed480ad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.45,
        "x": 0.05,
        "y": 0.58
      },
      "kind": "quote",
      "text": "MedImmune Ventures invests in companies with early to late stage products and technologies, in early (e.g. seed) to late (e.g. mezzanine) rounds of financing.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1141798b-ae1c-4f79-bae0-850acd2375dd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.45,
        "x": 0.05,
        "y": 0.78
      },
      "kind": "quote",
      "text": "We believe that in the current financial environment, there is a growing role for corporate venture capital funds such as MedImmune Ventures",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "484c36cd-91c0-4b2d-9a1d-a3414649474b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.54,
        "y": 0.51
      },
      "kind": "quote",
      "text": "This venture can have a decisive effect on the development of life science in Sweden",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c87dc70-7d1b-417d-baa5-b9de7c36a95d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.05,
        "y": 0.31
      },
      "kind": "quote",
      "text": "[We] invest in private companies which develop small and large molecules, vaccines, pharmaceutical technologies and platforms. We also seek investments in medical device, diagnostic, imaging and healthcare IT companies...",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "64a250dd-64b2-43ea-9698-4507dba089a5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.45,
        "x": 0.54,
        "y": 0.71
      },
      "kind": "quote",
      "text": "In our case the hub worked as planned. It's given us new partnerships and interactions [...]. You can also engage Astra employees as consultants, which is very valuable.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a832ec87-c9ef-4560-b1a6-4298bd6db03a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "This venture can have a decisive effect on the development of life science in Sweden - Birgitta Losman, President Västra Götaland Development Board",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd951-acb6-775d-928a-8f0a38a6258b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.04,
        "y": 0.08
      },
      "kind": "title",
      "text": "Medimmune Ventures and BioVentureHub press clippings",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dae7ba3b-dc71-4a8e-89f4-85558242ecba",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 26,
      "from": 21,
      "name": "Zoom In",
      "slug": "06-zoom-in",
      "bestFor": "Technical deep-dives, case studies, detailed analysis",
      "matchId": "019dd95a-088b-72c8-b7e2-e50f73c26705",
      "evidence": "Each case (MTGx, Volvo VC, AstraZeneca) gets a detail slide + press-clipping page.",
      "position": 6,
      "objective": "Deep-dive on each Swedish CV case in the appendix",
      "structure": "The Big Picture -> Key Area of Focus -> Specific Detail -> Implication",
      "confidence": 75,
      "description": "Start broad, then progressively focus on specific details that prove your point"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}